These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6018961)

  • 21. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and signification of hypercalciuria in calcium stone formers.
    Ulmann A
    Contrib Nephrol; 1984; 37():13-6. PubMed ID: 6713866
    [No Abstract]   [Full Text] [Related]  

  • 23. Uric acid saturation in calcium nephrolithiasis.
    Coe FL; Strauss AL; Tembe V; Le Dun S
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal lithiasis: the internist's viewpoint 1986].
    Jaeger P
    Schweiz Med Wochenschr; 1986 Jul; 116(27-28):902-8. PubMed ID: 3738461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian variations of blood and urinary constituents in renal stone formers.
    Singh RK; Bansal A; Bansal SK; Rai SP
    Prog Clin Biol Res; 1990; 341B():551-7. PubMed ID: 2217342
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects.
    Marshall RW; Cochran M; Hodgkinson A
    Clin Sci; 1972 Jul; 43(1):91-9. PubMed ID: 5040764
    [No Abstract]   [Full Text] [Related]  

  • 27. A method for discrimination between calcium oxalate kidney stone formers and normals.
    Sarig S; Garti N; Azoury R; Wax Y; Perlberg S
    J Urol; 1982 Sep; 128(3):645-9. PubMed ID: 6214645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic.
    Ryall RL; Marshall VR
    Br J Urol; 1983 Feb; 55(1):1-5. PubMed ID: 6824849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can obese stone formers follow dietary recommendations?
    Torricelli FC; De S; Li I; Sarkissian C; Monga M
    J Endourol; 2014 Feb; 28(2):248-51. PubMed ID: 24032438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent data on the urinary excretion of oxalic acid in oxalic renal lithiasis].
    Thomas J; Melon JM; Thomas E; Steg A; Desgrez P; Aboulker P
    Ann Urol (Paris); 1972 Feb; 6(1):31-3. PubMed ID: 5012700
    [No Abstract]   [Full Text] [Related]  

  • 34. [Allopurinol induced electrolyte and metabolism changes in the urine of patients with kidney stones].
    Schwille PO; Jügelt U; Sigel A
    Urologe A; 1972 Jul; 11(4):185-9. PubMed ID: 5071601
    [No Abstract]   [Full Text] [Related]  

  • 35. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers.
    Coe FL; Moran E; Kavalich AG
    J Chronic Dis; 1976 Dec; 29(12):793-800. PubMed ID: 1010873
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of food quantity and quality on the biochemical risk of renal stone formation.
    Esperto F; Miano R; Marangella M; Trinchieri A
    Scand J Urol; 2018 Jun; 52(3):225-229. PubMed ID: 29607709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of renal stones may be prevented by restoring normal urinary composition.
    Pak CY
    Proc Eur Dial Transplant Assoc; 1983; 20():371-85. PubMed ID: 6361751
    [No Abstract]   [Full Text] [Related]  

  • 38. A retrospective analysis of the metabolic status of stone formers in the New York City metropolitan areas.
    Hatch M; Schepers A; Grunberger I; Godec CJ
    N Y State J Med; 1991 May; 91(5):196-200. PubMed ID: 1857571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium crystalluria in recurrent renal-stone formers.
    Robertson WG; Peacock M; Nordin BE
    Lancet; 1969 Jul; 2(7610):21-4. PubMed ID: 4182793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.